loadpatents
name:-0.013792037963867
name:-0.010421991348267
name:-0.0058310031890869
Greve; Daniel Rodriguez Patent Filings

Greve; Daniel Rodriguez

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greve; Daniel Rodriguez.The latest application filed is for "substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors".

Company Profile
6.12.11
  • Greve; Daniel Rodriguez - Ballerup DK
  • Greve; Daniel Rodriguez - Stenlose N/A DK
  • Greve; Daniel Rodriguez - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
Grant 11,384,096 - Andrews , et al. July 12, 2
2022-07-12
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
Grant 11,292,799 - Andrews , et al. April 5, 2
2022-04-05
Substituted Azetidine Dihydrothienopyridines And Their Use As Phosphodiesterase Inhibitors
App 20210079012 - ANDREWS; Mark ;   et al.
2021-03-18
Substituted Azetidine Dihydrothienopyrimidines And Their Use As Phosphodiesterase Inhibitors
App 20210070769 - ANDREWS; Mark ;   et al.
2021-03-11
Bicyclic amines as novel JAK kinase inhibitors
Grant 10,851,116 - Greve , et al. December 1, 2
2020-12-01
5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors
Grant 10,799,507 - Larsen , et al. October 13, 2
2020-10-13
5-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NOVEL JAK KINASE INHIBITORS
App 20200009147 - LARSEN; Mogens ;   et al.
2020-01-09
Bicyclic Amines As Novel Jak Kinase Inhibitors
App 20190382418 - GREVE; Daniel Rodriguez ;   et al.
2019-12-19
Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors
Grant 9,346,809 - Nielsen , et al. May 24, 2
2016-05-24
Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof
Grant 9,233,964 - Schou , et al. January 12, 2
2016-01-12
Substituted pyridine derivatives
Grant 8,299,071 - Tornoe , et al. October 30, 2
2012-10-30
Heterocyclic Compounds As Jak Receptor And Protein Tyrosine Kinase Inhibitors
App 20120178740 - Nielsen; Simon Feldb.ae butted.k ;   et al.
2012-07-12
Subsituted Pyridine Derivatives
App 20110003811 - Tornoe; Christian Wenzel ;   et al.
2011-01-06
Substituted pyridine derivatives
Grant 7,812,020 - Tornoe , et al. October 12, 2
2010-10-12
Substituted Pyrimidine Derivatives
App 20100137311 - Khanzhin; Nikolay ;   et al.
2010-06-03
Substituted pyrimidine derivatives
Grant 7,683,058 - Khanzhin , et al. March 23, 2
2010-03-23
Substituted aniline derivatives
Grant 7,601,870 - Tornoe , et al. October 13, 2
2009-10-13
Use Of Kcnq-openers For Treating Or Reducing The Symptoms Of Schizophrenia
App 20090118285 - Husum Bak-Jensen; Henriette ;   et al.
2009-05-07
Substituted Pyridine Derivatives
App 20080318953 - Tornoe; Christian Wenzel ;   et al.
2008-12-25
Substituted pyrimidine derivatives
App 20070066612 - Khanzhin; Nikolay ;   et al.
2007-03-22
Substituted aniline derivatives
App 20060155121 - Tornoe; Christian Wenzel ;   et al.
2006-07-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed